Rgd (arg-gly-asp) coupled to (neuro)peptides
CA 2407514 C · Owner: Van Hagen, Petrus Martinus · Inventors: Van Hagen, Petrus Martinus; Krenning, Eric Paul; De Jong, Marion
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to compounds having a binding affinity for both the .alpha.v.beta.3 receptor and a(neuro)peptide receptor in particular the somatostatin receptor which compound comprises a first , peptide part comprising at least once the amino acid sequence Arg-Gly-Asp, and a second peptide part coupled thereto optionally , via a linker, which second peptide part is a (neuro) peptide.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 26, 2001 and granted March 29, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 26, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 26, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.